The Endoscopic Stricture Management Device Market is experiencing strong momentum as the global healthcare industry increasingly shifts toward minimally invasive interventions to treat gastrointestinal and urological strictures. Valued at US$ 901.23 million in 2024, the market is projected to expand at a steady CAGR of 5.99% from 2025 to 2032, driven by improved diagnostic technologies, rising...